SERPINC1 p.M313T Variant Induces Aberrant O-Glycosylation and Leads to Conformational Instability-Related Transient Antithrombin Deficiency
Thrombosis and Haemostasis · 31.03.2026
DOI: 10.1055/a-2832-6199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 31.03.2026. Verfasst von Changming Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Gefördert von: National Key R&D Program of China, General Program of National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Congenital antithrombin (AT) deficiency, primarily caused by SERPINC1 variants, is a major risk factor for venous thromboembolism (VTE). We previously reported the SERPINC1 p.M313T variant in three VTE probands with normal AT activity and antigen levels. This study aims to elucidate its pathogenetic mechanism.
Methods
Thrombin generation test (TGT), thermal stability, native-urea PAGE, in vitro protein expression, and enzymatic assays were performed. Glycosylation analysis was conducted using glycosidase treatment, and structural analysis was performed through molecular dynamics simulation.
Results
AT in probands' plasma samples exhibited reduced thermostability and increased proportions of denatured and latent forms compared with normal pooled plasma. The recombinant AT-M313T protein exhibited increased inhibitory activity, consistent with findings in proband plasma based on AT activity and TGT. Despite this enhanced activity, the mutant protein demonstrated reduced thermostability and a marked tendency to transition into the latent form, potentially predisposing carriers to thrombosis under stress conditions. These characteristics may result from the introduction of abnormal O-linked glycosylation within the breach region, confirmed in both plasma-derived and recombinant AT. Molecular dynamics simulation revealed a less compact structure, with increased spacing in the shutter region and enhanced flexibility of the reactive center loop.
Conclusion
The SERPINC1 p.M313T variant exhibits dual characteristics of high inhibitory activity and low structural stability, which together contribute to the transient AT deficiency. These findings suggest that AT deficiency may be underdiagnosed and highlight the importance of integrating techniques such as native-urea PAGE into standard diagnostic workflows to identify variants associated with structural abnormalities.
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Collaborative Innovation Center of Hematology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Changming Chen, Liya Lin, Lei Li
Förderung
- National Key R&D Program of China
- General Program of National Natural Science Foundation of China
Zitieren
APA
Chen, C., Mao, Y., Lin, L., Li, E., Zhang, K., Wu, X., Li, L., Wu, W., Ding, Q., Wang, X., & Dai, J. (2026). SERPINC1 p.M313T Variant Induces Aberrant O-Glycosylation and Leads to Conformational Instability-Related Transient Antithrombin Deficiency. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2832-6199
Vancouver
Chen C, Mao Y, Lin L, Li E, Zhang K, Wu X, et al. SERPINC1 p.M313T Variant Induces Aberrant O-Glycosylation and Leads to Conformational Instability-Related Transient Antithrombin Deficiency. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2832-6199
BibTeX
@article{Chen2026,
author = {Chen, Changming and Mao, Yinqi and Lin, Liya and Li, Enhao and Zhang, Ke and Wu, Xi and Li, Lei and Wu, Wenman and Ding, Qiulan and Wang, Xuefeng and Dai, Jing},
title = {SERPINC1 p.M313T Variant Induces Aberrant O-Glycosylation and Leads to Conformational Instability-Related Transient Antithrombin Deficiency},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2832-6199}
}
EUVIMED